The labeling for Tymlos (abaloparatide) has been updated to include additional information regarding the mechanism of action (MOA) of the drug. Tymlos, a human parathyroid hormone related peptide ...
Clinicians should avoid routine off-label use of certain bone graft substitutes in patients younger than 18 years of age with bone disorders because of the risk for serious injury, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results